Nootropic Agents
Showing 1 - 25 of 5,241
Cognitive Change Trial in Granada (Nootropic, Placebo)
Completed
- Cognitive Change
- Nootropic
- Placebo
-
Granada, SpainJonatan Ruiz Ruiz
May 17, 2022
Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis
Not yet recruiting
- Erythropoietin Resistant Anemia (EPO Resistant Anemia)
- (no location specified)
Sep 22, 2023
Anesthesia, General, Neuromuscular Transmission Disorders Trial in Brussels (Sevoflurane, Propofol)
Recruiting
- Anesthesia, General
- Neuromuscular Transmission Disorders
-
Brussels, BelgiumCHU Brugmann
Jan 19, 2023
Neuromuscular Blockade, Critical Illness, Neurologic Findings Trial (Sugammadex, Neostigmine)
Not yet recruiting
- Neuromuscular Blockade
- +2 more
- (no location specified)
Aug 14, 2023
Pulmonary Disease Trial in Seoul (Iohexol (320mgI/mL) with 120kVp, Iohexol (320mgI/mL) with 100kVp, Iohexol (270mgI/mL) with
Not yet recruiting
- Pulmonary Disease
- Iohexol (320mgI/mL) with 120kVp
- +3 more
-
Seoul, Seocho-gu, Korea, Republic ofSeoul St. Mary's Hospital, The Catholic University of Korea
Jul 21, 2023
Immunosuppressants to Postoperative Infection and Death
Recruiting
- Organ Transplantation
- +2 more
- Immunosuppressive Agents
-
Taichung, TaiwanChung Shan Medical University
Nov 6, 2023
Dentin Hypersensitivity Trial in Alexandria (Hurriseal desensitizer, Gluma desensitizer)
Completed
- Dentin Hypersensitivity
- Hurriseal desensitizer
- Gluma desensitizer
-
Alexandria, EgyptFaculty of Dentistry, Alexandria University
Oct 27, 2023
Metastatic Renal Cell Carcinoma Trial in Lebanon, Burlington (Sunitinib, Temsirolimus)
Active, not recruiting
- Metastatic Renal Cell Carcinoma
-
Lebanon, New Hampshire
- +1 more
Aug 9, 2022
Erythropoiesis Stimulating Agents for Anemia Management in
Completed
- Anemia of Chronic Kidney Disease
- +2 more
-
Giza, Egyptthe Memorial Souad Kafafi University Hospital
Jan 24, 2023
Uncontrolled Hypertension, Resistant Hypertension Trial in Worldwide (Baxdrostat, Placebo)
Not yet recruiting
- Uncontrolled Hypertension
- Resistant Hypertension
- Baxdrostat
- Placebo
-
Saraland, Alabama
- +122 more
Sep 6, 2023
Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Canakinumab
- Placebo
-
Charlestown, Massachusetts
- +11 more
Nov 11, 2022
Fragile X Syndrome, FXS, Fra(X) Syndrome Trial in Chicago (BPN14770, Placebo)
Completed
- Fragile X Syndrome
- +2 more
- BPN14770
- Placebo
-
Chicago, IllinoisRush University Medical Center
Dec 1, 2020
An Organoid-based Functional Precision Medicine Trial in
Not yet recruiting
- Osteosarcoma
- standard of care biopsy
- (no location specified)
Sep 26, 2023
CIPN - Chemo-Induced Peripheral Neuropathy, Breast Cancer Trial in Copenhagen (Elasto-Gel™ mitts for hands: TM7008, and slippers
Recruiting
- CIPN - Chemotherapy-Induced Peripheral Neuropathy
- Breast Cancer
- Elasto-Gel™ mitts for hands: TM7008, and slippers for feet: SL3000; Southwest Technologies, Inc., North Kansas City, MO, USA
-
Copenhagen, DenmarkMaria E Lendorf
Jun 23, 2023
Traumatic Pulp Exposure in Children Trial in Cairo (MTA Cement, propolis nano particle, curcumin nanoparticles)
Recruiting
- Traumatic Pulp Exposure in Children
- MTA Cement, propolis nano particle, curcumin nanoparticles
-
Cairo, EgyptDalia Elasser
Sep 6, 2023
Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +
Recruiting
- Colorectal Cancer
- +4 more
- NUC-3373 + leucovorin
- +8 more
-
Boston, Massachusetts
- +9 more
Jan 23, 2023
Pulpitis Reversible, Pulp Exposure, Dental Trial (pulpotomy, cone beam computed tomography (CBCT) assessment)
Not yet recruiting
- Pulpitis Reversible
- Pulp Exposure, Dental
- pulpotomy
- cone beam computed tomography (CBCT) assessment
- (no location specified)
Apr 1, 2023
Kidney Transplant; Complications, CMV Trial (Letermovir 480 mg once daily, Historical/Control)
Not yet recruiting
- Kidney Transplant; Complications
- CMV
- Letermovir 480 mg once daily
- Historical/Control
- (no location specified)
Aug 14, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- INE963
- +3 more
- (no location specified)
Feb 17, 2023
Carcinoma, Hepatocellular, Hepatoma Trial in Seongnam, Seoul (Regorafenib/Nivolumab)
Completed
- Carcinoma, Hepatocellular
- Hepatoma
-
Seongnam, Korea, Republic of
- +2 more
Dec 4, 2022
Neuromuscular Blockade, Anesthesia, Surgery Trial in Salt Lake City (BX1000, Rocuronium Bromide)
Recruiting
- Neuromuscular Blockade
- +2 more
- BX1000
- Rocuronium Bromide
-
Salt Lake City, UtahResearch Center
Jan 6, 2023
Antigens or Therapeutic Agents on in Vitro Human Intestinal
Recruiting
- Intestine Disease
-
Erlangen, GermanyDepartment of Medicine 1, Hector Center for Nutrition, Exercise
Jan 12, 2023